Eton Pharmaceuticals Inc. (ETON)

AI Score

Unlock

15.82

0.03 (0.19%)

At close: Apr 25, 2025, 3:59 PM

15.82

0.00%

After-hours: Apr 25, 2025, 04:05 PM EDT

Eton Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019	Q2 2019	Q1 2019	Q4 2018	Q3 2018	Q2 2018	Q1 2018	Q4 2017
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017
Cash & Equivalents	14.94M	20.26M	17.69M	16.66M	21.39M	22.07M	21.57M	14.71M	16.3M	13.38M	17.05M	15.23M	14.41M	22.71M	25.8M	25.11M	21.3M	7.33M	10.27M	12.34M	12.07M	11.78M	14.95M	19.58M	26.73M	6.6M	8.95M	11.21M	13.16M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	12K	12K	12K	12K	12K	12K	12K	12K	12K	12K	12K	12K	21K	23K	32K	36K	40K	81K	52K	58K	61K	40K	44K	48K	52K	454K	251K	156K	32K
Receivables	5.36M	5.59M	4.87M	4.24M	3.41M	3.5M	3.08M	2.87M	1.85M	1.5M	834K	796K	5.47M	385K	303K	300K	48K	-754K	-844K	205K	473K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	15.23M	1.94M	2.07M	2.32M	911K	1.05M	816K	437K	557K	481K	531K	510K	550K	334K	1.24M	1.35M	1.24M	1.7M	1.71M	1.73M	380K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	5.49M	1.96M	799K	n/a	1.13M	541K	867K	1.1M	1.29M	1.06M	1.36M	2.22M	3.18M	2.44M	1.73M	551K	2.12M	754K	844K	1.07M	2.09M	330K	n/a	1.94M	n/a	n/a	n/a	n/a	n/a
Total Current Assets	41.02M	29.75M	25.43M	24.26M	26.84M	27.16M	26.33M	19.12M	20M	16.42M	19.78M	18.75M	23.6M	25.86M	29.07M	30.27M	24.7M	9.79M	12.82M	15.34M	15.01M	12.11M	16.75M	21.53M	27.5M	6.8M	9.16M	11.35M	13.29M
Property-Plant & Equipment	209K	226K	255K	131K	150K	147K	195K	225K	260K	115K	150K	193K	219K	257K	299K	339K	1M	917K	1.03M	1.15M	1.28M	1.36M	1.45M	1.44M	773K	268K	233K	203K	119K
Goodwill & Intangibles	34.88M	5.85M	6.12M	6.39M	4.74M	4.21M	4.39M	4.57M	4.75M	4.97M	3.11M	4.24M	3.62M	463K	500K	537K	575K	612K	650K	688K	725K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	35.1M	6.09M	6.39M	6.53M	4.9M	4.37M	4.6M	4.81M	5.03M	5.1M	3.27M	4.45M	3.86M	743K	831K	912K	1.62M	1.61M	1.74M	1.9M	2.06M	1.4M	1.49M	1.49M	825K	722K	484K	359K	151K
Total Assets	76.12M	35.84M	31.82M	30.79M	31.74M	31.53M	30.93M	23.93M	25.03M	21.52M	23.05M	23.2M	27.46M	26.61M	29.91M	31.19M	26.32M	11.39M	14.56M	17.24M	17.07M	13.51M	18.24M	23.02M	28.33M	7.53M	9.65M	11.71M	13.44M
Account Payables	4.17M	2.68M	2.13M	2.26M	1.85M	1.71M	2.3M	1.23M	1.77M	1.05M	1.3M	2.13M	1.77M	3.27M	1.52M	1.76M	2.34M	2.21M	1.95M	1.18M	575K	549K	883K	3.21M	1.42M	793K	868K	801K	539K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-79K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	4.66M	5.02M	5.38M	1.54M	1.54M	1.34M	1.03M	708K	364K	n/a	1.42M	1.09M	749K	726K	280K	219K	159K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	n/a	4.13M	n/a	-87K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Liabilities	19.95M	19.73M	18.22M	15.3M	16.24M	10.39M	9.59M	7.49M	6.46M	4.66M	3.81M	3.48M	4.56M	5.36M	3.11M	3.2M	3.79M	3.22M	2.74M	2.05M	1.96M	1.11M	1.46M	3.66M	2.02M	1.2M	1.13M	947K	793K
Long-Term Debt	29.81M	n/a	n/a	n/a	n/a	4.2M	4.55M	5.11M	5.38M	5.68M	5.99M	6.33M	5.26M	5.55M	6.01M	6.35M	6.76M	6.79M	4.79M	4.57M	4.54M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	1.83M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.58M	1.02M	603K	n/a
Total Long-Term Liabilities	31.75M	126K	145K	n/a	22K	4.24M	4.62M	5.19M	5.49M	5.68M	5.99M	6.33M	5.28M	5.59M	6.06M	6.43M	6.86M	6.79M	4.79M	4.57M	4.56M	52K	86K	119K	1.42M	1.58M	1.02M	603K	n/a
Total Liabilities	51.7M	19.86M	18.36M	15.3M	16.26M	14.63M	14.21M	12.69M	11.95M	10.34M	9.8M	9.81M	9.84M	10.95M	9.17M	9.63M	10.66M	10.01M	7.53M	6.62M	6.52M	1.16M	1.54M	3.77M	2.02M	2.77M	2.15M	1.55M	793K
Total Debt	29.92M	126K	4.88M	5.11M	5.46M	5.78M	6.16M	6.53M	6.52M	6.39M	6.36M	6.33M	6.7M	6.68M	6.81M	7.16M	7.14M	7.01M	4.95M	4.57M	4.56M	52K	86K	119K	n/a	n/a	n/a	n/a	n/a
Common Stock	27K	26K	26K	26K	26K	26K	26K	26K	25K	25K	25K	25K	25K	25K	25K	24K	24K	21K	21K	21K	18K	18K	18K	18K	18K	6K	6K	6K	6K
Retained Earnings	-107.89M	-107.3M	-107.92M	-104.88M	-104.07M	-101.81M	-101.23M	-105.79M	-103.13M	-104.05M	-101M	-99.44M	-94.11M	-95.15M	-89.06M	-87.04M	-92.16M	-84.47M	-77.97M	-73.24M	-64.19M	-61.49M	-56.53M	-53.28M	-45.87M	-19.81M	-16.17M	-12.36M	-8.64M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	-0.00	n/a	n/a	n/a	0.00	n/a	n/a	n/a	n/a	n/a	n/a	n/a	0.00	n/a	n/a	n/a	-0.00	n/a	0.00	-0.00	-21.16M	-20.43M	-19.71M	n/a
Shareholders Equity	24.43M	15.98M	13.46M	15.49M	15.48M	16.89M	16.73M	11.24M	13.08M	11.18M	13.24M	13.38M	17.63M	15.66M	20.74M	21.55M	15.66M	1.39M	7.03M	10.62M	10.55M	12.35M	16.7M	19.24M	26.3M	4.75M	7.5M	10.16M	12.13M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a